MARKET

PAVM

PAVM

Pavmed
NASDAQ
0.3290
-0.0120
-3.52%
After Hours: 0.3355 +0.0065 +1.98% 18:31 12/05 EST
OPEN
0.3500
PREV CLOSE
0.3410
HIGH
0.3541
LOW
0.3204
VOLUME
217.41K
TURNOVER
--
52 WEEK HIGH
1.250
52 WEEK LOW
0.3040
MARKET CAP
9.76M
P/E (TTM)
-0.4823
1D
5D
1M
3M
1Y
5Y
1D
PAVmed Shareholders Approve Reverse Stock Split and Share Reduction
Reuters · 5h ago
Weekly Report: what happened at PAVM last week (1124-1128)?
Weekly Report · 4d ago
Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb
NASDAQ · 4d ago
Weekly Report: what happened at PAVM last week (1117-1121)?
Weekly Report · 11/24 09:58
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus
TipRanks · 11/19 03:57
PAVmed’s Earnings Call: Triumphs and Trials
TipRanks · 11/18 00:06
Weekly Report: what happened at PAVM last week (1110-1114)?
Weekly Report · 11/17 09:57
PAVmed Announces Q3 2025 Financial Results and Updates
TipRanks · 11/13 13:32
More
About PAVM
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.

Webull offers PAVmed Inc stock information, including NASDAQ: PAVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PAVM stock methods without spending real money on the virtual paper trading platform.